Category: Include on Menu
-
Aptevo Therapeutics Shares Soar Following 100% Remission Rate in AML Trial
Aptevo Therapeutics (NASDAQ:APVO) saw its stock jump 57% on Tuesday after announcing that Cohort 3 of its Phase 1b/2 RAINIER trial for acute myeloid leukemia (AML) achieved a 100% remission rate. The study is testing mipletamig, Aptevo’s CD123 x CD3 bispecific antibody, alongside venetoclax and azacitidine in newly diagnosed AML patients who are ineligible for…
-
Soluna Shares Jump After Securing $100 Million Credit Line
Soluna Holdings Inc (NASDAQ:SLNH) saw its stock climb 7.5% Tuesday following the announcement of a flexible credit facility of up to $100 million from Generate Capital, PBC. The green data center developer, which transforms excess renewable energy into computing power for Bitcoin mining and AI operations, plans to use an initial $12.6 million draw to…
-
BrainsWay Shares Jump Following FDA Approval of Accelerated Depression Therapy
BrainsWay Ltd. (NASDAQ:BWAY) saw its stock rise 6.3% on Tuesday after the U.S. Food and Drug Administration (FDA) approved an accelerated treatment protocol for the company’s Deep Transcranial Magnetic Stimulation (Deep TMS) system for major depressive disorder (MDD). The new clearance allows the acute treatment phase to be completed in just six days rather than…
-
ADTRAN Shares Slide Following $150 Million Convertible Notes Announcement
ADTRAN Holdings, Inc. (NASDAQ:ADTN) saw its stock drop 11.1% Tuesday after the company revealed plans to issue $150 million in convertible senior notes due 2030 through a private placement for qualified institutional investors. The senior, unsecured notes will carry semi-annual interest payments and mature on September 15, 2030, unless redeemed, repurchased, or converted earlier. ADTRAN…
-
NanoVibronix Shares Drop Sharply Following Share Resale Filing
NanoVibronix Inc. (NASDAQ:NAOV) saw its stock tumble 15.9% in premarket trading on Tuesday after the company filed a prospectus for a potential resale of up to 1,347,935 shares of common stock by existing shareholders. The filing covers 880,099 shares convertible from Series H Convertible Preferred Stock and 467,836 shares from exercisable warrants. The Series H…
-
Rocket Lab Shares Drop Following $750 Million At-the-Market Offering Announcement
Rocket Lab USA Inc. (NASDAQ:RKLB) saw its stock dip 4.2% in premarket trading on Tuesday after the aerospace firm revealed a new at-the-market (ATM) program to raise up to $750 million by selling common shares. The satellite launch company will collaborate with several investment banks to facilitate the sales, including BofA Securities, Cantor Fitzgerald, BTIG,…
-
Ralph Lauren Shares Slip Following Release of Long-Term Growth Plan
Ralph Lauren (NYSE:RL) stock dropped 4% Tuesday morning after the luxury brand unveiled its refreshed strategic growth plan, “Next Great Chapter: Drive,” along with a long-term financial outlook during its investor day in New York City. The company outlined a three-year financial roadmap, projecting revenue growth in the mid-single digits compounded annually in constant currency…
-
Lantern Pharma Shares Soar as LP-184 Cancer Drug Hits Key Trial Goals
Shares of Lantern Pharma (NASDAQ:LTRN) jumped 10% following the announcement that its cancer therapy LP-184 met all primary endpoints in a Phase 1a trial, showing a favorable safety profile and promising antitumor activity in patients with advanced solid tumors. The AI-driven oncology company said the open-label, multicenter study evaluated LP-184 in 63 patients with advanced,…
-
Bloom Energy Shares Jump After Morgan Stanley Lifts Price Target to Street-High
Shares of Bloom Energy Corp. (NYSE:BE) surged 8% Tuesday morning following a major price target upgrade from Morgan Stanley, driven by the company’s expanding role in powering AI data centers. Analyst David Arcaro boosted his price target on Bloom Energy from $44 to $85, maintaining an Overweight rating. The revised target implies significant upside from…
-
Chris Holmes Joins Avalanche Foundation Board to Strengthen Regulatory Ties
The Avalanche Foundation has named Chris Holmes, a Conservative member of the UK House of Lords, to its board of directors, the organization announced Tuesday, September 16, 2025. The appointment comes as blockchain adoption continues to accelerate globally, positioning the foundation to gain greater political credibility and influence in international regulatory conversations. Holmes is well-known…